Seniors have until the end of the year to switch Medicare drug plans to get a better deal. But many will pass up the chance to save hundreds of dollars a year in prescription costs.
The reason: With dozens of drug plans on the market, many seniors get overwhelmed at the prospect of changing plans, even if a different one would better suit their needs and lower their costs.
But with the average premium for a Medicare drug plan increasing 11 percent in 2010, consumer advocates say seniors have even more reason to check out the options and consider their costs.
Robert Lowenstein, a 91-year-old retired Washington attorney, chose a UnitedHealthcare-AARP drug plan in 2006, when the stand-alone policies first became available. He trusted AARP, which was UnitedHealthcare’s marketing partner, and has stuck with the policy because he figured changing would be confusing and time-consuming.
But a look at the “Prescription Drug Plan Finder” on Medicare’s Web site ( www.medicare.gov) indicates that Lowenstein would save about $400 a year by selecting a different UnitedHealthcare plan or a policy offered by CVS Caremark.
Similarly, his wife, Elizabeth, 82, would save $450 a year by switching from her UnitedHealthcare plan, reducing their drug costs by more than 20 percent.
Only an average of 7 percent of the 17 million seniors on Medicare drug plans switch plans each year, according to the Centers for Medicare and Medicaid Services, the federal agency that runs Medicare.
Experts on Medicare say this suggests that millions of beneficiaries could be paying more than they should for their drug coverage.
“I know I could probably do better, but it’s what I’m used to, and it’s a hassle to change,” said Molly Schuchat, 81, a D.C. resident who has been with the same Blue Cross and Blue Shield drug plan since 2006.
Yet, according to the Medicare Web site, Schuchat could save as much as $744, about 20 percent of her costs, by changing plans next year.
The Medicare drug benefit was created by Congress in 2003 to help those seniors – one in four at the time – who didn’t have prescription-drug coverage.
Rather than giving all seniors the same coverage, Congress decided to have private companies offer the benefit through competing plans. As a result, insurers offer different levels of coverage for different drugs.
Some experts say the competition has held down costs, but some seniors – and their children – say the wide array of plans can be daunting, making it unnerving or too perplexing to change.
Medicare’s easy-to-use “plan finder” allows seniors to plug in their medications and see which plan would have the lowest overall annual costs. But many seniors are uncomfortable going online or unable to use computers to sort through the different policies.
Last year, only 688,000 seniors, or 2.5 percent, went online to enroll in Medicare drug or health plans. The rest did it the old-fashioned way: by telephone or letter.
“With these drug plans, you really do have to do your homework each year,” said Howard Houghton, a coordinator at the Virginia Insurance Counseling and Assistance Program.
Some seniors, he added, have begun to reconsider their options in response to the latest premium increases and the faltering economy, but many have not.
The price for such inaction will get higher next year as the average monthly premium for a Medicare drug plan rises to $38.85 a month, according to figures from the the Kaiser Family Foundation based on data from the Centers for Medicare and Medicaid Services. That’s 50 percent more than seniors paid in 2006.
The average premium for the most popular drug plan – UnitedHealthcare’s AARP Medicare RX Preferred, which has nearly 3 million customers – has jumped 50 percent to $39.39 in 2010 from $26.31 in 2006, according to the Kaiser Family Foundation.
The average premium for Humana’s PDP Enhanced – the second most popular plan, with 1.6 million customers – will be $41.53 next year, 182 percent higher than in 2006. The actual premiums vary by state.
For some seniors, these premium increases will be unavoidable. But others could save substantial amounts of money by checking out a variety of plans.
Geoffrey Joyce, a senior economist at the Rand Corp., a nonprofit think tank based in Santa Monica, Calif., said health plans benefit from seniors’ fear of changing plans.
“If they feel like they have them locked in, they can raise prices and get away with it,” he said.
Humana officials say it is inaccurate to suggest that they initially offered artificially low prices on their plans in a bid to grab market share. They say they have had to raise prices to reflect the increased costs of providing the coverage.
The large health insurers that sell drug plans say that seniors don’t switch plans because they’re satisfied with their coverage.
“Many (Medicare) Part D members are extremely or very satisfied with the Medicare prescription plan in which they’re currently enrolled,” said Jonathan Stone, a spokesman for Minnesota-based UnitedHealthcare.
The company, the nation’s largest private health insurer, has the largest number of Medicare drug members, about 4.3 million seniors, or about 25 percent of the market.
Some smaller health insurers say it’s difficult trying to persuade seniors to switch from more-established and well-known plans such as UnitedHealthcare, Blue Cross and Blue Shield and Humana.
“It’s very challenging because I don’t think most seniors are really shopping plans,” said Jaydip Dattaray, chief operating officer at New York-based Fox Insurance Co., which has about 85,000 Medicare drug plan members.
In figuring out their prospective drug costs, seniors need to look beyond premiums and also consider deductibles and co-payments, which can vary by drug.
In addition, they also have to consider whether they want to pay more in premiums to have some coverage in the Medicare program’s coverage gap, commonly called the “doughnut hole.”
In 2010, this lapse in coverage will begin after an enrollee incurs $2,830 in total drug spending and end when an enrollee has spent a total of $4,550 out of pocket. After that, beneficiaries are responsible for just 5 percent of their drug costs.
The Democrats’ health-care overhaul bills in the House and the Senate could have a major impact on the Medicare prescription-drug program. The House bill would close the gap in coverage by 2019, although the Senate bill wouldn’t.
Under both bills, starting in 2010, beneficiaries would be able to buy brand-name drugs for half price once they’re in the coverage gap. The annual enrollment period would also be moved up a month to start in mid-October.